Sessa Capital (Master) L.P. 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | Sessa Capital (Master) L.P. | 6,607,100 9.990% | 4,125,817 (+166.28%) | Filing |